Related Experiment Video
Updated: May 7, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Screening for and management of elevated Lp(a)
Michael B Boffa1, Marlys L Koschinsky
1Department of Chemistry & Biochemistry, University of Windsor, 401 Sunset Avenue, Windsor, Ontario, Canada, mboffa@uwindsor.ca.
Current Cardiology Reports
|September 24, 2013
Summary
Lipoprotein(a) (Lp(a)) is a causal factor for cardiovascular disease. Research is exploring optimal patient groups for Lp(a) testing, management strategies, and risk reduction efficacy.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Epidemiology
Background:
- Lipoprotein(a) (Lp(a)) is a recognized cardiovascular risk factor.
- Genetic studies confirm Lp(a) as causal for atherothrombotic disease, not just a marker.
- Clinical utilization of Lp(a) for risk prediction is a recent development.
Purpose of the Study:
- To review recent advancements in Lp(a) research.
- To explore the clinical integration of Lp(a) in risk assessment and management.
- To address outstanding questions regarding Lp(a) and cardiovascular risk.
Main Methods:
- Review of genetic studies.
- Summary of basic laboratory research findings.
- Analysis of epidemiological data.
- Focus on clinical practice implications.
Main Results:
- Lp(a) is established as a causal factor in atherothrombotic disease.
- Ongoing research addresses optimal patient selection for Lp(a) testing.
- The effectiveness of Lp(a) reduction on clinical outcomes is under investigation.
Conclusions:
- Further research is needed to define the precise role of Lp(a) in clinical practice.
- Understanding the molecular mechanisms of Lp(a) risk is crucial.
- Effective management strategies for elevated Lp(a) are a key area of focus.
Related Concept Videos
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...